New Talk: Forward Engineering Cell Therapy Production Capabilities to Save Patient Lives
John Lee, PhD, Head of Cell Therapy , Center for Breakthrough Medicines
There is a critical shortage in cell therapy manufacturing slots that has resulted in long waitlists for CAR T eligible patients and lengthy vein-to-vein times from apheresis to infusion. This has translated into physicians being forced to make hard choices on which of their patients can get potentially life-saving therapies. Against this backdrop, CDMO’s like Center for Breakthrough Medicines have the chance to alleviate that pain by bringing flexible capacity to market.
In this talk, you will learn:
– How to forward engineer a facility that enables modularity to accommodate an array of processes and increase efficiency and throughput
– What to consider from new regulatory draft guidance on CAR T CMC, testing and process controls
– Why a close partnership with IT and Digital will push the pedal on innovation with the right automation and monitoring technologies
Watch the full talk below.